Development of bioconjugate-based delivery systems for nucleic acids

A Wahane, V Kasina, M Pathuri, C Marro-Wilson… - RNA, 2025 - rnajournal.cshlp.org
Nucleic acids are a class of drugs that can modulate gene and protein expression by various
mechanisms, namely, RNAi, mRNA degradation by RNase H cleavage, splice modulation …

Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges

R Ruchi, GM Raman, V Kumar… - Expert Opinion on Drug …, 2025 - Taylor & Francis
Introduction Antisense oligonucleotide (ASO) was established as a viable therapeutic option
for genetic disorders. ASOs can target RNAs implicated in various diseases, including …

Advancements in cell-penetrating monoclonal antibody treatment

SP Pradeep, R Bahal - Oncotarget, 2024 - pmc.ncbi.nlm.nih.gov
Advancements in cell-penetrating monoclonal antibody treatment - PMC Skip to main content
Here's how you know Official websites use .gov A .gov website belongs to an official government …